Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Symposia

Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology)

ea0056s7.1 | Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology) | ECE2018

Triac: hormone, metabolite and drug.

Visser Theo

The prohormone thyroxine (T4) is the major product secreted by the thyroid gland, while most actions of thyroid hormone (TH) are initiated by binding of the active hormone 3,3′,5-triiodothyronine (T3) to nuclear receptors. The biological activity of TH is thus determined by the intracellular T3 concentration in target tissues, which depends on 1) the circulating concentrations of T4 and T3, 2) the activity of deiodinases catalyzing the conversion of T4 to T3 or to recept...

ea0056s7.2 | Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology) | ECE2018

Tetrac as an antiangiogenic agent in cancer

Schmohl Kathrin Alexandra

In 2005, Bergh et al. first described a cell surface receptor for thyroid hormones (TH) T3 and T4 on integrin αvβ3 that is expressed on tumour cells and dividing endothelial cells. The deaminated T4 derivative tetraiodothyroacetic acid (tetrac) is a specific inhibitor of integrin-mediated TH action. Building on Paul Davis’ pioneer studies, we are investigating the effects of TH and tetrac on mesenchymal stem cells (MSCs), important progenitor cells of t...

ea0056s7.3 | Expanding the spectrum of thyroid hormone use (Endorsed by the European Journal of Endocrinology) | ECE2018

Thyroid hormones, metabolites, and analogs: Potential therapies for non-alcoholic fatty liver disease and other metabolic conditions

Yen Paul

Thyroid hormones (THs) are known to regulate both lipid, glucose, and cholesterol metabolism. These effects have led to biochemical and molecular studies on the roles that they and their metabolites have on these processes. Additionally, TH analogs have been developed to improve metabolic conditions such as hypertriglyceridemia hypercholesterolemia, and obesity while minimizing side effects such as tachycardia and osteoporosis that occur in hyperthyroidism. Typically, these an...